Thomas Gad Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

Thomas Gad is CHIEF BUSINESS OFFICER of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 0 shares of YMAB, which is worth approximately $0. The most recent transaction as insider was on Mar 01, 2021, when has been sold 9,000 shares (Common Stock) at a price of $35.51 per share, resulting in proceeds of $319,590. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Thomas Gad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2021	SELL Open market or private sale	$319,590 $35.51 p/Share	9,000 Reduced 100.0%	0 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$18,000 $2.0 p/Share	9,000 Added 50.0%	9,000 Common Stock
Feb 16 2021	SELL Open market or private sale	$329,560 $47.08 p/Share	7,000 Reduced 100.0%	0 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Feb 01 2021	SELL Open market or private sale	$293,930 $41.99 p/Share	7,000 Reduced 100.0%	0 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Jan 19 2021	SELL Open market or private sale	$325,570 $46.51 p/Share	7,000 Reduced 100.0%	0 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Jan 05 2021	SELL Open market or private sale	$345,520 $49.36 p/Share	7,000 Reduced 100.0%	0 Common Stock
Jan 05 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Dec 28 2020	SELL Open market or private sale	$363,860 $51.98 p/Share	7,000 Reduced 100.0%	0 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Dec 16 2020	SELL Open market or private sale	$371,070 $53.01 p/Share	7,000 Reduced 100.0%	0 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Dec 11 2020	SELL Open market or private sale	$2,558,500 $51.17 p/Share	50,000 Reduced 100.0%	0 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	$100,000 $2.0 p/Share	50,000 Added 50.0%	50,000 Common Stock
Dec 10 2020	SELL Open market or private sale	$2,537,500 $50.75 p/Share	50,000 Reduced 100.0%	0 Common Stock
Dec 10 2020	BUY Exercise of conversion of derivative security	$100,000 $2.0 p/Share	50,000 Added 50.0%	50,000 Common Stock

Thomas Gad

CHIEF BUSINESS OFFICER

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Value

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB

Account